S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents


In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.

Related Videos
Marco Taglietti
preterm birth
Related Content
© 2023 MJH Life Sciences

All rights reserved.